Search

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine ® technology

Dr. Collier presents "Pregnancy Immunology in Action: Maternal Immune Responses and Infant Protection"

https://www.webmd.com/vaccines/news/20250219/cm/new-studies-show-rsv-va…

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody nirsevimab among pregnant women seen during the 2023-24 season, the first RSV season the vaccine and...

News story about the scientific premise behind our clinical trial for Long COVID patients https://clinicaltrials.gov/study/NCT06597396

Beth Israel Lahey Health (BILH) marked the 2024 International Day of Women in Science by highlighting women’s valuable contributions to science and reaffirming BILH’s commitment to greater gender diversity and inclusivity in research and innovation. Hosted by Chief Academic Officer, Gyongyi Szabo...

On this episode, Panicos Shangaris interviews Professor Ai-ris Y. Collier from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston on her paper "Altered Cytokine Production in Human Intervillous Blood T Cells in Preeclampsia".